找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Recent Developments in Graves’ Ophthalmopathy; Mark F. Prummel,Wilmar M. Wiersinga (Professor of Book 2000 Springer Science+Business Medi

[复制链接]
楼主: Inveigle
发表于 2025-3-25 04:38:41 | 显示全部楼层
,Immunosuppressive management of Graves’ ophthalmopathy, of both, are the most frequently used immunosuppressive therapies, but other treatments like cyclosporine, azathioprine, intravenous immunoglobulins, and plasma exchange, have also been used (Table 1).
发表于 2025-3-25 10:36:47 | 显示全部楼层
,Future Research in Graves’ ophthalmopathy,acter too, and that the TSH-R is an important antigen also in the pathogenesis of the eye signs. This chapter tries to summarize recent developments in endocrine autoimmunity in general and Graves’ ophthalmopathy in particular.
发表于 2025-3-25 12:20:21 | 显示全部楼层
Book 2000e disease. Each chapter is written by anexpert and truly represents the current state of the art on theparticular topic. This book can therefore almost be considered atextbook on this enigmatic disorder. ..Recent Developments in Graves‘ Ophthalmopathy. is designed forall those interested in this dis
发表于 2025-3-25 18:11:39 | 显示全部楼层
发表于 2025-3-25 23:44:12 | 显示全部楼层
,Thyroid management in Graves’ ophthalmopathy,nts with Graves’ hyperthyroidism, subclinical evidence for orbital disease is present in almost all patients.. This close association has always been the most pertinent reason to think that the ophthalmopathy and the thyroid disorder are actually two manifestations of the same condition: Graves’ disease.
发表于 2025-3-26 04:13:51 | 显示全部楼层
,Radiotherapy for Graves’ ophthalmopathy,treatments and the treatment schedules used. The prevention of keloid formation was the most widely accepted indication, followed by Graves’ ophthalmopathy. Thus, radiotherapy for this orbital disorder is generally accepted and applied worldwide.
发表于 2025-3-26 07:27:36 | 显示全部楼层
发表于 2025-3-26 11:51:44 | 显示全部楼层
发表于 2025-3-26 14:04:09 | 显示全部楼层
发表于 2025-3-26 19:21:24 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-4 18:49
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表